Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1

A Chinese medicine granule, Shu-Feng-Xuan-Fei (SFXF), is critical for viral clearance in early phase of influenza virus infection. In this study, 72 ICR mice were randomly divided into six groups: normal control group, virus control group, Oseltamivir group, low-dose SFXF, medium-dose SFXF, and high...

Full description

Bibliographic Details
Main Authors: Na-na Lu, Qi Liu, Li-gang Gu, Shi-jie Ge, Jun Wu, Qiu Ze-ji, Ze-ji Qiu, Hong-chun Zhang, En-xiang Chao, Zhuo-nan Yu
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2014/976364
id doaj-825b137c6e384ce1b0e8b705f4aa57db
record_format Article
spelling doaj-825b137c6e384ce1b0e8b705f4aa57db2020-11-24T22:20:22ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882014-01-01201410.1155/2014/976364976364Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1Na-na Lu0Qi Liu1Li-gang Gu2Shi-jie Ge3Jun Wu4Qiu Ze-ji5Ze-ji Qiu6Hong-chun Zhang7En-xiang Chao8Zhuo-nan Yu9Laboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaDepartment of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, ChinaDepartment of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaA Chinese medicine granule, Shu-Feng-Xuan-Fei (SFXF), is critical for viral clearance in early phase of influenza virus infection. In this study, 72 ICR mice were randomly divided into six groups: normal control group, virus control group, Oseltamivir group, low-dose SFXF, medium-dose SFXF, and high-dose SFXF. Mice were anesthetized and inoculated with 4LD50 of influenza virus A (H1N1) except normal control group. Oseltamivir group received 11.375 mg·kg−1·d−1 Oseltamivir Phosphate. SFXF 3.76, 1.88 and 0.94 g·kg−1·d−1 were administrated to mice in all SFXF groups. Each group was in equal dose of 0.2ml daily for 4 consecutive days. Mice were sacrificed and then total RNA was extracted in lung tissue. Some genes involved in T-cell-mediated immunity were selected by DNA microarray. These candidate genes were verified by Real-Time PCR and western immunoblotting. Compared with virus control group, in Toll-like receptor signaling pathway, 12 virus-altered genes were significantly reduced following medium-dose SFXF treatment. Eighteen antigen processing presentation-associated genes were upregulated by medium-dose SFXF. In the process of T cell receptor signaling pathway, 19 genes were downregulated by medium-dose SFXF treatment. On exploration into effector T cells activation and cytokines, all of altered genes in virus control group were reversed by medium-dose SFXF. Real-time PCR and western immunoblotting showed that the regulation of medium-dose SFXF in IL-4, IFN-γ, TNF-α, IL-1β, TLR7, MyD88, p38, and JNK was superior to Oseltamivir and high-dose SFXF group. Therefore, SFXF granules could reduce influenza infected cells and activation of T cells.http://dx.doi.org/10.1155/2014/976364
collection DOAJ
language English
format Article
sources DOAJ
author Na-na Lu
Qi Liu
Li-gang Gu
Shi-jie Ge
Jun Wu
Qiu Ze-ji
Ze-ji Qiu
Hong-chun Zhang
En-xiang Chao
Zhuo-nan Yu
spellingShingle Na-na Lu
Qi Liu
Li-gang Gu
Shi-jie Ge
Jun Wu
Qiu Ze-ji
Ze-ji Qiu
Hong-chun Zhang
En-xiang Chao
Zhuo-nan Yu
Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1
Evidence-Based Complementary and Alternative Medicine
author_facet Na-na Lu
Qi Liu
Li-gang Gu
Shi-jie Ge
Jun Wu
Qiu Ze-ji
Ze-ji Qiu
Hong-chun Zhang
En-xiang Chao
Zhuo-nan Yu
author_sort Na-na Lu
title Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1
title_short Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1
title_full Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1
title_fullStr Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1
title_full_unstemmed Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1
title_sort gene expression profiles underlying selective t-cell-mediated immunity activity of a chinese medicine granule on mice infected with influenza virus h1n1
publisher Hindawi Limited
series Evidence-Based Complementary and Alternative Medicine
issn 1741-427X
1741-4288
publishDate 2014-01-01
description A Chinese medicine granule, Shu-Feng-Xuan-Fei (SFXF), is critical for viral clearance in early phase of influenza virus infection. In this study, 72 ICR mice were randomly divided into six groups: normal control group, virus control group, Oseltamivir group, low-dose SFXF, medium-dose SFXF, and high-dose SFXF. Mice were anesthetized and inoculated with 4LD50 of influenza virus A (H1N1) except normal control group. Oseltamivir group received 11.375 mg·kg−1·d−1 Oseltamivir Phosphate. SFXF 3.76, 1.88 and 0.94 g·kg−1·d−1 were administrated to mice in all SFXF groups. Each group was in equal dose of 0.2ml daily for 4 consecutive days. Mice were sacrificed and then total RNA was extracted in lung tissue. Some genes involved in T-cell-mediated immunity were selected by DNA microarray. These candidate genes were verified by Real-Time PCR and western immunoblotting. Compared with virus control group, in Toll-like receptor signaling pathway, 12 virus-altered genes were significantly reduced following medium-dose SFXF treatment. Eighteen antigen processing presentation-associated genes were upregulated by medium-dose SFXF. In the process of T cell receptor signaling pathway, 19 genes were downregulated by medium-dose SFXF treatment. On exploration into effector T cells activation and cytokines, all of altered genes in virus control group were reversed by medium-dose SFXF. Real-time PCR and western immunoblotting showed that the regulation of medium-dose SFXF in IL-4, IFN-γ, TNF-α, IL-1β, TLR7, MyD88, p38, and JNK was superior to Oseltamivir and high-dose SFXF group. Therefore, SFXF granules could reduce influenza infected cells and activation of T cells.
url http://dx.doi.org/10.1155/2014/976364
work_keys_str_mv AT nanalu geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1
AT qiliu geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1
AT liganggu geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1
AT shijiege geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1
AT junwu geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1
AT qiuzeji geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1
AT zejiqiu geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1
AT hongchunzhang geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1
AT enxiangchao geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1
AT zhuonanyu geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1
_version_ 1725775475067846656